نتائج البحث - "Davide Melisi"

1

Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma

المساهمون: Trestini, I, Paiella, S, Sandini, M, Sperduti, I, Elio, G, Pollini, T, Melisi, D, Auriemma, A, Solda, C, Bonaiuto, C, Tregnago, D, Avancini, A, Secchettin, E, Bonamini, D, Lanza, M, Pilotto, S, Malleo, G, Salvia, R, Bovo, C, Gianotti, L, Bassi, C, Milella, M

المصدر: Annals of Surgical Oncology. 27:5325-5334

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a01d204ded54ff3c6fe81f2f92536a68Test
https://doi.org/10.1245/s10434-020-08515-5Test

2

Target Therapy and Immunotherapy in Gastric Cancer

المؤلفون: Simona Casalino, Davide Melisi, Valeria Merz

المصدر: Gastric Cancer: the 25-year R-Evolution ISBN: 9783030731571

مصطلحات موضوعية: Chemotherapy, business.industry, medicine.medical_treatment, Cancer, Immunotherapy, Precision medicine, medicine.disease, Targeted therapy, Ramucirumab, Regimen, Trastuzumab, Cancer research, medicine, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::bcbd8c6469be6b86492f80abb3f4089dTest
https://doi.org/10.1007/978-3-030-73158-8_28Test

3

Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer

المؤلفون: Yumin Zhao, Teresa Macarulla, Karim A. Benhadji, Rocio Garcia-Carbonero, M. Lanasa, Davide Melisi, Do Youn Oh, Shawn T. Estrem, Michael Man, Antoine Hollebecque, Emiliano Calvo, Leena Gandhi, Susan C. Guba, Anna M. Varghese, Erkut Borazanci, Valeria Merz, Camilla Zecchetto, Emin Avsar, Ivelina Gueorguieva

المساهمون: Institut Català de la Salut, [Melisi D] Digestive Molecular Clinical Oncology Research Unit, Section of Medical Oncology, Università degli Studi di Verona, Verona, Italy. [Oh DY] Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. [Hollebecque A] Institut Gustave Roussy, Villejuif, France. [Calvo E] START Madrid–CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain. [Varghese A] Memorial Sloan Kettering Cancer Center, New York, New York, USA. [Borazanci E] HonorHealth Research Institute, Scottsdale, Arizona, USA. TGen, Phoenix, Arizona, USA. [Macarulla T] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Durvalumab, Time Factors, medicine.medical_treatment, Receptor, Transforming Growth Factor-beta Type I, B7-H1 Antigen, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Immunology and Allergy, Other subheadings::/therapeutic use [Other subheadings], Neoplasm Metastasis, Immune Checkpoint Inhibitors, neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias pancreáticas [ENFERMEDADES], RC254-282, Clinical/Translational Cancer Immunotherapy, Aged, 80 and over, biology, clinical trials as topic, terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Antibodies, Monoclonal, Middle Aged, Progression-Free Survival, Europe, 030220 oncology & carcinogenesis, Disease Progression, Quinolines, Molecular Medicine, Female, immunotherapy, Antibody, Signal Transduction, Adult, medicine.medical_specialty, Combination therapy, Immunology, therapies, investigational, 03 medical and health sciences, Refractory, Pharmacokinetics, Internal medicine, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Republic of Korea, Pàncrees - Càncer - Tractament, medicine, Galunisertib, tumor microenvironment, Humans, Protein Kinase Inhibitors, Aged, Pharmacology, Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Pancreatic Neoplasms [DISEASES], business.industry, Otros calificadores::/uso terapéutico [Otros calificadores], diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Immunotherapy, medicine.disease, Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], United States, Pancreatic Neoplasms, 030104 developmental biology, tumor biomarkers, biology.protein, Avaluació de resultats (Assistència sanitària), Pyrazoles, business, Progressive disease